Advertisements


Kodiak Sciences reports "promising" safety data from KSI-301 Phase 1b study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 10th, 2020

Kodiak Sciences Announces Encouraging Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet AMD, DME and RVO at Angiogenesis, Exudation, and Degeneration 2020 Meeting

Encouraging safety profile continues with zero cases of intraoc.....»»

Category: blogSource: benzingaFeb 8th, 2020

Kodiak Sciences announces safety, efficacy from Phase 1b study of KSI-301

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 13th, 2019

Kodiak Sciences announces emerging durability data from Phase 1 study of KSI-301

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 15th, 2019

Akari Therapeutics Reports Second Quarter 2019 Financial Results And Highlights Recent Clinical Progress

- Positive early safety and efficacy data with nomacopan Phase II clinical study in patients with mild-to-moderate bullous pemph.....»»

Category: earningsSource: benzingaAug 29th, 2019

Aptevo Therapeutics Reports Second Quarter 2019 Financial Results

Reports Positive Preliminary Top-Line Safety Data for APVO210Phase 1 Single Ascending Dose (SAD) Clinical Study Advances APVO210 into Phase 1 Multiple Ascending Dose (MAD) Study Co.....»»

Category: earningsSource: benzingaAug 9th, 2019

Kodiak Sciences announces interim data from ongoing Phase 1B study of KSI-301

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 28th, 2019

Myovant Sciences Provides Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019

-Announced positive Phase 3 results from LIBERTY 1 study evaluating relugolix combination therapy in women with uterine fibroids- -Data from four additional Phase 3 clinical studies ex.....»»

Category: earningsSource: benzingaMay 24th, 2019

Wave Life Sciences Plunges After DMD Study Data Readout

Wave Life Sciences (WVE) announces final safety data from a phase I DMD study evaluating suvodirsen and provides design update for phase II/III stage developm.....»»

Category: dealsSource: nytApr 17th, 2019

Arcutis Biotherapeutics reports preliminary data from Phase 2 study of ARQ-151

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 31st, 2020

Alector reports "promising" preliminary data from AL001 Ph. 1b, Phase 2 studies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 28th, 2020

CytoDyn reports safety data from Phase 2 trial of leronlimab

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 21st, 2020

Genentech says Phase IIIb STASEY study data reinforces Hemlibra safety profile

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 13th, 2020

Myovant Sciences announces additional data from Phase 3 HERO study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: smallbizSource: nytMay 29th, 2020

Why Mersana Therapeutics"s Stock Is Trading Higher Today

Mersana Therapeutics (NASDAQ: MRSN) shares are trading higher on Wednesday. The company reported interim safety, tolerability and efficacy data from the ongoing expansion portion of its Phase 1 study evaluating XMT-1536. read more.....»»

Category: blogSource: benzingaMay 27th, 2020

Myovant Sciences Provides Recent Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2020

- Co-primary endpoints and six key secondary endpoints met in Phase 3 SPIRIT 2 study in women with endometriosis, with results from the Pha.....»»

Category: earningsSource: benzingaMay 18th, 2020

Gilead Sciences reports positive data in trial of remdesivir as treatment for COVID-19

Gilead Sciences Inc. said that its experimental COVID-19 therapy remdesivir met the main goal in a government-funded clinical trial and that a shorter dosing regimen was as successful as a longer one in a separate study......»»

Category: topSource: marketwatchApr 29th, 2020

Corbus expects safety data from Phase 1 study of CRB-4001 in 2020

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 12th, 2020

Provention Bio reports "positive" data from Phase 1b PREVAIL study of PRV-3279

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 12th, 2020

Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

Completed enrollment for the pivotal REST-ON Phase 3 study in Q4 2019; data readout expected in Q2 2020 Raised $65 million in gross proceeds from privat.....»»

Category: earningsSource: benzingaMar 12th, 2020

Kodiak Sciences study data align with bullish expectations, says Roth Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 10th, 2020